Extended knowledge of 123536-14-1

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.123536-14-1, you can also check out more blogs about123536-14-1

123536-14-1, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 123536-14-1, name is (R)-3-Aminoquinuclidine dihydrochloride, introducing its new discovery.

SALTS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS

The object of the invention relates to the salts of encenicline formed with inorganic and organic acids of general formula (I), as well as to the use of these for the production of pharmaceutical preparations primarily suitable for the treatment of diseases involving cognitive disorder (schizophrenia, Alzheimer’s disease).

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.123536-14-1, you can also check out more blogs about123536-14-1

Reference£º
Quinuclidine – Wikipedia,
Quinuclidine | C7H125N | ChemSpider